ArticleFrontiers in oncology2025

Untargeted metabolomics revealed urinary metabolic pattern for discriminating prostate cancer from benign prostatic hyperplasia in Chinese participants.

Chenye Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.